Kriya Therapeutics Stock

Develops gene therapies that deliver targeted genetic treatments for chronic and complex diseases.

Buy

Buy Kriya Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Kriya Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Kriya Therapeutics develops gene therapies designed to treat chronic and complex diseases. The company engineers genetic medicines that deliver therapeutic genes to target tissues to address underlying causes of disease. Its platform focuses on scalable manufacturing and precision delivery to improve treatment effectiveness.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

Palo Alto, CA

Buy

Buy Kriya Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Kriya Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Kriya Therapeutics Management Team

Kriya Therapeutics people and management

  • Co-Founder, CEO, Board Member
    Shankar Ramaswamy
  • Co-Founder
    Fraser Wright
  • CFO
    Sachiyo Minegishi
  • COO
    Mark Chen
  • Board Member
    Akshay Rai
  • Board Member
    Ilan Oren
  • Board Member
    James C. Momtazee
  • Board Member
    Keith Manchester
  • Board Member
    Neelaksh Varshney
  • Board Member
    Roger Jeffs
  • Board Member
    Ryan Gallagher
  • Board Member
    Saira Ramasastry
  • Board Member
    Trit Garg

Investors

Major Kriya Therapeutics investors

  • Alumni Ventures Group

  • Amplo

  • Bluebird Ventures

  • CAM Capital

  • Dexcel Pharma

  • Foresite Capital

  • Foresite Capital Management LLC

  • Individuals

  • JDRF T1D Fund

  • Lightswitch Capital

  • Narya Capital

  • Patient Square Capital

  • Paul Manning

  • Peter Thiel

  • Premji Invest

  • QVT Financial LP

  • Transhuman Capital

  • Woodline Partners LP

Kriya Therapeutics Valuations & Financials

Gain Insights Into Kriya Therapeutics Stock Valuation & Share Prices

View real-time NPM data on Kriya Therapeutics stock including daily Kriya Therapeutics stock price estimates, valuation history, and historical share price information. Access Kriya Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Kriya Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Kriya Therapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like Kriya Therapeutics

  • Clio Cloud Based Legal Technology-Logo

    Clio

    Healthcare & Life Sciences

    Comprehensive legal practice management software designed to help law firms manage their operations more efficiently.

  • Array Behavioral Care

    Healthcare & Life Sciences

    Provider of telepsychiatry and telebehavioral health services.

  • Sollis Health

    Healthcare & Life Sciences

    Delivers personalized primary care and clinical services with a focus on patient‑centered care delivery.

  • Colossal Laboratories & Biosciences

    Healthcare & Life Sciences

    Pioneering biotech that reconstructs genomes for species restoration and ecosystem revitalization with innovative genetic engineering.

  • Avalyn Pharma

    Healthcare & Life Sciences

    Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.

  • Ancora Heart

    Healthcare & Life Sciences

    Develops trans-catheter systems for treating mitral regurgitation linked to congestive heart failure.

  • PrognomIQ

    Healthcare & Life Sciences

    Develops advanced tests combining proteomic, genomic, and metabolomic data for early disease detection and treatment.

  • Rula

    Healthcare & Life Sciences

    Online platform connecting people with licensed therapists for virtual mental health counseling and support services.

  • Vizgen

    Healthcare & Life Sciences

    A leader in spatially resolved, single-cell transcriptomics, the company provides innovative solutions for visualizing gene expression in situ.

FAQ

Questions?

We have answers

Buy Kriya Therapeutics Stock

Kriya Therapeutics stock does not trade on public stock exchanges. Kriya Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Kriya Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Kriya Therapeutics Stock

Kriya Therapeutics Stock does not trade on public stock exchanges. In order to sell Kriya Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Kriya Therapeutics Stock Price

Kriya Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Kriya Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Kriya Therapeutics Stock Ticker Symbol

There is no ticker symbol for Kriya Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Kriya Therapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kriya Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Kriya Therapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Kriya Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Kriya Therapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Kriya Therapeutics IPO

Kriya Therapeutics is a private company and has not had an IPO. There is currently no Kriya Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Kriya Therapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.